Koers China National Accord Medicines Corporation Ltd.
Aandelen
000028
CNE0000009N6
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,49 CNY | +0,41% | -4,80% | +25,87% |
Omzet 2024 * | 80,01 mld. 11,05 mld. 10,19 mld. | Omzet 2025 * | 85,75 mld. 11,84 mld. 10,92 mld. | Marktkapitalisatie | 18,73 mld. 2,59 mld. 2,38 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,77 mld. 244 mln. 225 mln. | Nettowinst (verlies) 2025 * | 1,92 mld. 265 mln. 244 mln. | EV/omzet 2024 * | 0,23 x |
Nettoliquiditeiten 2024 * | 446 mln. 61,59 mln. 56,78 mln. | Nettoschuld 2025 * | 2,89 mld. 399 mln. 368 mln. | EV/omzet 2025 * | 0,25 x |
K/w-verhouding 2024 * |
11,5
x | K/w-verhouding 2025 * |
10,6
x | Werknemers | 39.449 |
Dividendrendement 2024 * |
2,06% | Dividendrendement 2025 * |
2,03% | Vrij verhandelbaar | 42,7% |
1 dag | +0,41% | ||
1 week | -4,80% | ||
1 maand | +3,87% | ||
3 maanden | +16,28% | ||
6 maanden | +19,72% | ||
Lopend jaar | +25,87% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zhao Xiong Lin
CEO | Chief Executive Officer | 57 | 01-12-08 |
Guo Lin Gu
DFI | Director of Finance/CFO | 49 | 28-05-20 |
Min Lin
CHM | Chairman | 59 | 01-12-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Zhao Xiong Lin
CEO | Chief Executive Officer | 57 | 01-12-08 |
Min Lin
CHM | Chairman | 59 | 01-12-08 |
Yi Jian Wu
BRD | Director/Board Member | 54 | 13-11-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 36,49 | +0,41% | 1 920 130 |
30-05-24 | 36,34 | -0,85% | 2 437 059 |
29-05-24 | 36,65 | -0,81% | 5 217 988 |
28-05-24 | 36,95 | -4,40% | 5 693 303 |
27-05-24 | 38,65 | +0,83% | 3 852 153 |
slotkoers Shenzhen S.E., 31 mei 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,87% | 2,59 mld. | |
-1,52% | 24,18 mld. | |
+3,67% | 8,46 mld. | |
+8,55% | 8,34 mld. | |
-23,71% | 7,64 mld. | |
+15,20% | 5,33 mld. | |
+2,68% | 4,12 mld. | |
-6,90% | 3,92 mld. | |
+5,56% | 3,89 mld. | |
+18,80% | 3,54 mld. |